We are live on ! Find out more
SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

27 hedge funds and large institutions have $186M invested in Sinovac Biotech, Ltd in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

160% more capital invested

Capital invested by funds: $71.4M → $186M (+$114M)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

8% more funds holding

Funds holding: 25 → 27 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
3
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$667

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$3K
2
FIM
Freedom Investment Management
Connecticut
-$2.21K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$72M – – –
SA
2
SAIF Advisors
Hong Kong
$69.8M +$69.8M +10,780,820 New
VC
3
Vivo Capital
California
$38.2M – – –
NAH
4
Neumann Advisory (HK)
Hong Kong
$2.04M – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$1.54M – – –
State Street
6
State Street
Massachusetts
$1.04M – – –
YMRC
7
Yorktown Management & Research Company
Virginia
$485K – – –
Skandinaviska Enskilda Banken (SEB)
8
Skandinaviska Enskilda Banken (SEB)
Sweden
$259K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$179K – – –
FIM
10
Freedom Investment Management
Connecticut
$119K -$2.21K -341 -2%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$106K – – –
UBS Group
12
UBS Group
Switzerland
$58K – – –
Northern Trust
13
Northern Trust
Illinois
$55K – – –
Morgan Stanley
14
Morgan Stanley
New York
$10K +$667 +100 +7%
Group One Trading
15
Group One Trading
Illinois
$3K – – –
FGAM
16
Financial Gravity Asset Management
Texas
$1K +$1K +123 New
JP Morgan Chase
17
JP Morgan Chase
New York
– -$3K -400 Closed

SVA Hedge Fund Activity: Q4 2020 in Review

27 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q4 2020, worth a combined $186M — up 160% from $71.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new SVA positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $667. The largest seller was JP Morgan Chase, exiting entirely with an estimated $3K sold.

  • 27 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q4 2020, up from 25 in Q3 2020.
  • Funds reported $186M of Sinovac Biotech, Ltd stock for Q4 2020, up 160% quarter-over-quarter.
  • 3 funds opened new Sinovac Biotech, Ltd positions in Q4 2020 and 1 closed out, a net change of +2 holders.
  • The largest Sinovac Biotech, Ltd buyer in Q4 2020 was Morgan Stanley, an estimated $667 added.
  • The largest Sinovac Biotech, Ltd seller in Q4 2020 was JP Morgan Chase, an estimated $3K sold.

Based on aggregated 13F filings for Q4 2020.